Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R125384-5mg | 5mg | In stock | $28.90 | |
R125384-25mg | 25mg | In stock | $117.90 | |
R125384-50mg | 50mg | In stock | $195.90 | |
R125384-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $260.90 | |
R125384-250mg | 250mg | In stock | $587.90 |
Cdk inhibitor
Synonyms | roscovitine|Seliciclib|186692-46-6|R-Roscovitine|(R)-roscovitine|CYC202|CYC-202|CYC 202|Seliciclib [INN]|(R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol|2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine|Seliciclib (Ros |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Cyclin-dependent kinase 5 inhibitor |
Product Description | Roscovitine (Seliciclib, CYC202) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM. It shows little effect on CDK4/6. Phase 2. |
ALogP | 3.2 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol |
---|---|
INCHI | InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 |
InChi Key | BTIHMVBBUGXLCJ-OAHLLOKOSA-N |
Canonical SMILES | CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3 |
Isomeric SMILES | CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3 |
WGK Germany | 3 |
PubChem CID | 160355 |
Molecular Weight | 354.45 |
PubChem CID | 160355 |
---|---|
ChEMBL Ligand | CHEMBL14762 |
CAS Registry No. | 186692-46-6 |
Wikipedia | Seliciclib |
RCSB PDB Ligand | RRC |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2220224 | Certificate of Analysis | Jun 12, 2024 | R125384 |
G2220199 | Certificate of Analysis | May 15, 2024 | R125384 |
G2220200 | Certificate of Analysis | May 15, 2024 | R125384 |
G2220206 | Certificate of Analysis | May 15, 2024 | R125384 |
G2220225 | Certificate of Analysis | May 15, 2024 | R125384 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 35.44, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 35.44, Max Conc. mM: 100 |
---|---|
Melt Point(°C) | 106-107 °C |
WGK Germany | 3 |
---|
1. Fukushima T et al.. (2019) Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic Calcium.. Cell Rep, 29 (12): (4144-4158.e7). [PMID:31851939] |